Medicine
Pharmacology
Lasting action against HIV
Researchers at American pharmaceutical company Gilead Sciences have published the results of clinical trials of a new long-acting antiretroviral against HIV
By Redação
Technology
Nanocellulose sensors
Microbial nanocellulose could be used to make electrochemical sensors that attach to the skin to monitor health conditions or physical performance
By Redação
Neuroscience
Early deficit
People with Huntington's disease tend to produce fewer neurons since birth
COVER
Saving time
Brazilian research centers negotiate deals to import vaccine production technology
COVID-19
Platform gathers data on Brazilians with COVID-19
The COVID-19 Data Sharing/BR platform is a repository of clinical, laboratory and demographic data on people diagnosed with the infection in the country
By Redação
Innovation
From cocoons to bones
A team has developed a potentially simpler, faster, and cheaper strategy for producing a biocompatible material that can be used as a scaffold for repairing long bones
By Redação
Good practices
List of retractions grows
It has been 10 years since German anesthesiologist Joachim Boldt was involved in one of the largest scientific misconduct scandals in history. Even today, the scandal continues
By Redação
Biomedical engineering
Green microbattery
Researchers from USP and Harvard develop a vegetable gelatin prototype for medical applications
Cover
The reality of data
Mapping and systematizing COVID-19 data is crucial to controlling the disease in Brazil
By Redação
Covid-19
Traditional Chinese medicine to treat COVID-19
China's government and state media are encouraging the use of traditional medicines and remedies to treat COVID-19, despite the lack of scientific support
By Redação
COVID-19
Novel coronavirus can damage the retina
Ophthalmologists at the Federal University of São Paulo suspect that Sars-CoV-2, the virus that causes COVID-19, can damage the retina
By Redação
Covid-19
Growing lung cells
São Paulo–based startup TissueLabs has created a platform that mimics the environment of the pulmonary epithelium to allow scientists to study how the SARS-CoV-2 virus, which causes COVID-19, affects the lungs
By Redação
Medicine
Gelatin optical fiber
Researchers used agar, a type of gelatin extracted from algae, to develop a biodegradable and biocompatible optical fiber
By Redação
Data
At least 125 COVID-19 vaccines are in development, with 10 already undergoing clinical trials
Vaccines in the clinical trials phase worldwide and in development in Brazil (as of May 27, 2020)
By Redação
Letter from the Editor | 292
Crucial numbers
Little is known about viruses. Existing on the boundary between the living and the nonliving, they are found in all environments where there is life. Their effects on living beings can be beneficial, harmless, or capable of triggering devastating epidemics, such as Ebola, Zika, and now, SARS-CoV-2. Although the number of species is estimated in... View Article
Retrospect
In the palm of the hand
A São Paulo physician developed a portable respirator in the 1950s
Cover
Science fights back
In just four months, 8,000 scientific articles have been published on Covid-19, more than 70 drugs tested against SARS-CoV-2, and the first vaccines trialed on humans
By Redação